Inquest hears repeated dismissal of sickle cell pain before Veronique Mwembo’s death
Veronique Mwembo’s final hospital admission has placed sickle cell disease and emergency care under an unforgiving light. Her family told an inquest that she was met with ridicule when she sought help for severe pain, a pattern they say worsened her mental health and left her afraid of the very place meant to treat her.
Mwembo, a 32-year-old mother and childminder from Norwich, died after administering pain medicines and antibiotics incorrectly, which caused damage to her blood vessels and led to cardiac arrest on 23 January. The coroner delivered a narrative conclusion, tying the immediate mechanism of death to the self-administration error while also laying out the broader context of her long struggle with sickle cell crises, recurrent hospital attendance, and mounting distress.
Her case is a stark reminder that pain in sickle cell disease is not a vague complaint waiting for interpretation. It is an acute vascular emergency driven by red cell abnormality, microvascular obstruction, and tissue ischemia.
Pain control delays collided with stigma and training gaps
Mwembo’s brother, Emmie Mwembo, said specialist teams treated her well, but front-line staff in emergency and general wards did not always recognize that her pain was real, severe, and clinically urgent. He described overheard comments from staff members referring to her as a “frequent flyer” and suggesting she was back again or only there for morphine. Those words carry more than emotional weight; they can shape triage decisions, delay analgesia, and erode trust in settings where speed matters most.
He said that on some occasions she waited up to six hours for appropriate pain relief. NHS guidance from NICE advises that people presenting to A&E with sickle cell pain should receive treatment within 30 minutes. A delay of that length can allow vaso-occlusive pain to intensify, deepen physiologic stress, and make every subsequent step harder, from hydration and monitoring to reassessment of the evolving crisis.
His testimony linked those repeated experiences to her mental health. Veronique later developed psychiatric symptoms, including auditory hallucinations that became worse around sickle cell crises. For families living with chronic hemoglobinopathy, the emotional burden is not separate from the disease process; it often develops beside it, shaped by pain, sleep disruption, repeated admissions, and the expectation of being doubted before being treated.
A lifelong genetic disorder that shaped every stage of her care
Born in 1993 in Katanga in the Democratic Republic of Congo, Mwembo moved to the UK with her family in 2006 after fleeing civil war. She had lived with sickle cell disease throughout her life. The disorder affects hemoglobin molecules in red blood cells and is more common among people of African, Caribbean, Middle Eastern, Mediterranean, and Asian origin.
The clinical course described at the inquest was familiar to many hematology teams: recurrent admissions, acute painful episodes, bacterial infections, abscesses, and periods of vulnerability that stretched far beyond one hospital stay. She was admitted again in November 2025 after becoming unwell and was treated for bacterial infections, abscesses in her arms, and other problems. Her condition initially improved, but the final collapse came suddenly when she went into cardiac arrest while video-calling her brother on 23 January.
That abrupt turn is difficult to separate from the chaotic physiology that can accompany severe infection, severe pain, and medication misadventure in a patient with underlying red cell disease. Sickle cell patients often arrive with complex presentations, and when pain is minimized or delayed, the margin for error narrows even further.
Blood disease care depends on recognition before crisis
John James, chief executive of the Sickle Cell Society, said being treated as drug-seeking is not uncommon for patients with the disease. His comments fit a familiar clinical pattern: when a patient’s pain history becomes a label, the label can displace assessment. In sickle cell care, that shift can be dangerous because pain is not a side issue. It is often the first sign of vaso-occlusion and an early signal that a patient needs rapid analgesia, fluids, reassessment, and, in some cases, escalation.
The society’s 2021 report No-One Is Listening identified systemic failures in emergency and general ward care for people with sickle cell disease. The inquest echoed that concern without needing to overstate it. The reported gaps were concrete: inconsistent recognition, non-mandatory staff training, and delays in treatment that should have been faster.
An NNUH representative said the trust had been building a new service for people with red cell diseases over the past year and had been offering training on sickle cell treatment to front-line staff since September, though the training was not mandatory. The coroner said she would write to the hospital chief executive urging consideration of mandatory training for staff treating sickle cell patients.
The bedside consequence of disbelief is measurable in suffering
Veronique Mwembo was described by her family as the kindest, most joyful, and warmest person. The language matters because it sits in painful contrast to the clinical encounters her relatives say she endured. A patient can be medically complex and profoundly unwell without being difficult, and sickle cell pain should never be filtered through suspicion before treatment begins.
Her death was caused by an immediate physiological event, but the inquest made plain that the path to that event was paved by repeated moments of missed recognition and delayed care. In sickle cell disease, those missed moments can accumulate into crisis, then into trauma, and finally into tragedy.
The unanswered question for hospitals is not whether sickle cell pain should be taken seriously. It already should be. The issue is whether training, triage discipline, and emergency response can be made consistent enough to prevent another patient from waiting hours for analgesia while being told, explicitly or implicitly, that their pain is not being believed.